What does Hyloris Developments do?
Hyloris Developments is a biopharmaceutical company that specializes in the development of innovative drug formulations. The company focuses on enhancing the therapeutic effectiveness and safety of existing medications through advanced delivery systems. Its mission is to improve patient outcomes by providing better treatment options in various therapeutic areas.
- Sectors
- Pharmacies
- Activities
- Signals
-
Reporting lossesReporting losses € -5.29M
The company reported a loss in the latest financial year.
Strong equityStrong equity € 17.94MStrong equity provides a buffer against setbacks.
Low riskLow risk 87.1%Good solvency (> 30%) points to long-term financial stability.
Good liquidityGood liquidity 5.76A healthy current ratio (≥ 1.5): enough current assets to cover short-term debt.
Positive cashflowPositive cashflow € 4.28MPositive operating cash flow in the latest financial year.
Positive EBITDAPositive EBITDA € 4.05MPositive EBITDA: operating activities are profitable.
High turnoverHigh turnover € 5.06MSubstantial turnover in the latest financial year.
Healthy social debtHealthy social debt 18.1%Social debts stay manageable relative to personnel costs.
Financial ratios
|
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2025
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2024
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2023
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2022
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
|---|---|---|---|---|
|
Turnover
|
€
5.06M
|
|
|
|
|
€
5.46M
|
€
4.09M
|
€
960K
|
€
956K
|
|
|
€
4.05M
|
€
2.84M
|
€
-227K
|
€
80K
|
|
|
€
-5.29M
|
€
-5.85M
|
€
-10.85M
|
€
-9.64M
|
|
|
€
17.94M
|
€
3.22M
|
€
9.07M
|
€
19.92M
|
|
|
87.06%
|
31.94%
|
61.40%
|
85.96%
|
|
|
€
2.67M
|
€
6.87M
|
€
5.70M
|
€
3.25M
|
|
|
€
1.63M
|
€
366K
|
€
375K
|
€
6.52M
|
|
|
13
|
11
|
11
|
9.80
|
Publications 18
All publications- Demissions, Nominations 26/09/2025
- Demissions, Nominations 05/03/2025
- Capital, Actions 25/02/2025
- Demissions, Nominations 19/05/2023
- Siege Social - Capital, Actions 22/09/2022
Frequently asked questions
Answers to the most common questions about Hyloris Developments, based on official government data and the filed annual accounts.
What is the VAT number of Hyloris Developments?
The VAT number of Hyloris Developments is BE0542.737.368.
How many employees work at Hyloris Developments?
In 2025, Hyloris Developments employed 13.00 full-time equivalents (FTE).
When was Hyloris Developments established?
Hyloris Developments was founded in 05-12-2013.
What is the official address of Hyloris Developments?
The official address of Hyloris Developments is Boulevard De Patience Et Beaujonc 3/1 Liège 4000.
What is the legal form of Hyloris Developments?
The juridical form of Hyloris Developments is Public limited company (NV/SA).
What is the annual revenue of Hyloris Developments?
The revenue of Hyloris Developments for the 2025 financial year was €5,058,073.
What does Hyloris Developments do?
Hyloris Developments is a biopharmaceutical company that specializes in the development of innovative drug formulations. The company focuses on enhancing the therapeutic effectiveness and safety of existing medications through advanced delivery systems. Its mission is to improve patient outcomes by providing better treatment options in various therapeutic areas.
Is Hyloris Developments a reliable company?
Hyloris Developments is a registered Rechtspersoon with company number 0542.737.368 and can be verified through the official CBE database.
What is the credit limit of Hyloris Developments?
The estimated credit limit of Hyloris Developments is €6,552,202.
Is Hyloris Developments still active?
Hyloris Developments currently has the status "Normal situation" and is active.